
What We're Reading: Mitigating Variant Spread; Vaccine Supply Garners Concern; Merck Ends Vaccine Development
President to sign travel ban meant to contain more contagious variants of coronavirus disease 2019 (COVID-19); limited vaccine supply concerns top health officials; Merck ends COVID-19 vaccine development.
President Biden to Restrict Travel
In an effort to mitigate the spread of emerging variants of coronavirus disease 2019 (COVID-19), President Joe Biden plans to sign a travel ban today on most non-US citizens who recently visited South Africa, the
Vaccine Supply Garners Concern From Health Officials
As the Biden adminstration progresses toward its goal of administering
Merck Ends Development of COVID-19 Vaccines
Following poor results in early-stage studies, Merck has announced it will end its development of 2 potential COVID-19 vaccines and instead focus on assessing the efficacy of 2 treatments for COVID-19 not yet approved by regulators. Reported by
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.